Trastuzumab deruxtecan (T-DXd) versus treatment of physician's choice (TPC) in patients (pts) with HER2-low unresectable and/or metastatic breast cancer (mBC): Results of DESTINY-Breast04, a randomized, phase 3 study.

被引：0

作者：

Modi, Shanu

Jacot, William

Yamashita, Toshinari

Sohn, Joohyuk

Vidal, Maria

Tokunaga, Eriko

Tsurutani, Junji

Ueno, Naoto T.

Chae, Yee Soo

Lee, Keun Seok

Niikura, Naoki

Park, Yeon Hee

Wang, Xiaojia

Xu, Binghe

Gambhire, Dhiraj

Yung, Lotus

Meinhardt, Gerold

Wang, Yibin

Harbeck, Nadia

Cameron, David A.

机构：

[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[2] Montpellier Univ, Inst Canc Montpellier ICM Val dAurelle, Montpellier, France

[3] Kanagawa Canc Ctr, Yokohama, Kanagawa, Japan

[4] Yonsei Canc Ctr, Seoul, South Korea

[5] Hosp Clin Barcelona, Barcelona, Spain

[6] Natl Hosp Org Kyushu Canc Ctr, Fukuoka, Japan

[7] Showa Univ, Adv Canc Translat Res Inst, Tokyo, Japan

[8] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[9] Kyungpook Natl Univ, Chilgok Hosp, Daegu, South Korea

[10] Natl Canc Ctr, Res Inst & Hosp, Goyang, South Korea

[11] Tokai Univ, Tokyo, Japan

[12] Samsung Med Ctr, Seoul, South Korea

[13] Chinese Acad Sci, Zhejiang Canc Hosp, Hangzhou, Peoples R China

[14] Chinese Acad Sci, Inst Canc & Basic Med, Hangzhou, Peoples R China

[15] Chinese Acad Med Sci, Coll Med, Canc Hosp, Beijing, Peoples R China

[16] Daiichi Sankyo Inc, Basking Ridge, NJ USA

[17] Ludwig Maximilians Univ LMU Hosp, Ctr Comprehens Canc, Munich, Germany

[18] Univ Edinburgh, Edinburgh Canc Res Ctr, Edinburgh, Midlothian, Scotland

[19] NHS Lothian, Edinburgh, Midlothian, Scotland

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 17期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LBA3

引用

页数：1